Learn More
Apexbio Technology LLC Docosanol (Abreua) 661-19-8 10g

Supplier: Apexbio Technology LLC A841610000
Docosanol Abreua (CAS 661-19-8) is a small-molecule inhibitor targeting herpes simplex virus (HSV) It is designed to inhibit viral entry processes thereby preventing HSV replication at the initial stage of infection Docosanol Abreua exerts its biological activity primarily through the inhibition of viral envelope fusion with host cell membranes In cell-based studies Docosanol Abreua demonstrates antiviral inhibition with an IC50 value typically in the range of approximately 2 5-5 M Based on these pharmacological properties Docosanol Abreua holds research potential in antiviral mechanism studies investigation of viral entry pathways and host pathogen interaction assays
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.